Zydus Lifesciences has secured a No Objection Certificate (NOC) from Health Canada for its innovative smoking cessation aid, marking a significant milestone in the company's global expansion strategy. This regulatory approval paves the way for Zydus to introduce its novel therapeutic option in the Canadian market, where smoking-related health burdens continue to be a major public concern.